Patel V. A short review on the association between
depression and diabetes. Int. J. Med. Sci. Public Health
(2014) 3: 3-5.
Li CL and Deng YJ. Oil-based formulations for oral
delivery of insulin. J. Pharm. Pharmacol . (2004) 56:
1101-7.
Pillai O and Panchagnula R. Insulin therapies - past,
present and future. Drug Discov. Today (2001) 6:
1056-61.
Ubaidulla U, Khar RK, Ahmed FJ and Panda AK.
Development and in-vivo evaluation of insulin-loaded
chitosan phthalate microspheres for oral delivery. J.
Pharm. Pharmacol. (2007) 59: 1345-51.
Bayat A, Larijani B, Ahmadian S, Junginger HE and
Rafiee-Tehrani M. Preparation and characterization of
(1)
(2)
(3)
(4)
(5)
Shamsa ES et al. / IJPR (2018), 17 (2): 442-459458
insulin nanoparticles using chitosan and its quaternized
derivatives. Nanomedicine (2008) 4: 115-20.
Sadeghi AM, Dorkoosh FA, Avadi MR, Weinhold M,
Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani
M and Junginger HE. Permeation enhancer effect
of chitosan and chitosan derivatives: Comparison of
formulations as soluble polymers and nanoparticulate
systems on insulin absorption in Caco-2 cells. Eur. J.
Pharm. Biopharm. (2008) 70: 270-8.
Radwant MA and Aboul-Enein HY. The effect of oral
absorption enhancers on the in-vivo performance of
insulin-loaded poly(ethylcyanoacrylate) nanospheres
in diabetic rats. J. Microencapsul. (2002) 19: 225-35.
Mesiha M, Plakogiannis F and Vejosoth S. Enhanced
oral absorption of insulin from desolvated fatty acid-
sodium glycocholate emulsions. Int. J. Pharm. (1994)
111: 213-6.
Morishita I, Morishita M, Takayama K, Machida
Y and Nagai T. Hypoglycemic effect of novel oral
microspheres of insulin with protease inhibitor in
normal and diabetic rats. Int. J. Pharm . (1992) 78:
9-16.
Bernkop-Schnürch A. The use of inhibitory agents
to overcome the enzymatic barrier to perorally
administered therapeutic peptides and proteins. J.
Control. Release (1998) 52: 1-16.
Takeuchi H, Yamamoto H, Niwa T, Hino T and
Kawashima Y. Enteral absorption of insulin in rats from
mucoadhesive chitosan-coated liposomes. Pharm. Res.
(1996) 13: 896-901.
Asada H, Douen T, Waki M, Adachi S, Fujita T and
Yamamoto A. Absorption characteristics of chemically
modified-insulin derivatives with various fatty acids in
the small and large intestine. J. Pharm. Sci. (1995) 84:
682-7.
Chen Y, Siddalingappa B, Chan PH and Benson
HA. Development of a chitosan-based nanoparticle
formulation for delivery of a hydrophilic hexapeptide,
dalargin. Biopolymers (2008) 90: 663-70.
Ito M, Ban A and Ishihara M. Anti-ulcer effects of
chitin and chitosan, healthy foods, in rats. Jpn. J.
Pharmacol. (2000) 82: 218-25.
Sieval AB, Thanoual M, Kotzkb AF, Verhoefa JC,
Brussee J and Junginger HE. Preparation and NMR
characterization of highly substitutedN-trimethyl
chitosan chloride. Carbohydr. Polym. (1998) 36: 157-
65.
Thanou M, Verhoef JC and Junginger HE. Oral
drug absorption enhancement by chitosan and its
derivatives. Adv. Drug Deliv. Rev. (2001) 52: 117-26.
Mao S, Bakowsky U, Jintapattanakit A and Kissel
T. Self-assembled polyelectrolyte nanocomplexes
between chitosan derivatives and insulin. J. Pharm.
Sci. (2006) 95: 1035-48.
Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin
KY, Wang Y, August JT and Leong KW. Chitosan-
DNA nanoparticles as gene carriers: Synthesis,
characterization and transfection efficiency. J. Control.
Release (2001) 70: 399-421.
Mahjub R, Dorkoosh F, Amini M, Khoshayand M and
Rafiee-Tehrani M. Preparation, statistical optimization,
and in-vitro characterization of insulin nanoparticles
composed of quaternized aromatic derivatives of
chitosan. AAPS PharmSciTech. (2011) 12: 1407-19.
Kadam RS, Bourne DW and Kompella UB.
Nano-advantage in enhanced drug delivery with
biodegradable nanoparticles: Contribution of reduced
clearance. Drug Metab. Dispos. (2012) 40: 1380-8.
Roller S and Covill N. The antifungal properties of
chitosan in laboratory media and apple juice. Int. J.
Food Microbiol. (1999) 47: 67-77.
Rhoades J and Roller S. Antimicrobial actions
of degraded and native chitosan against spoilage
organisms in laboratory media and foods. Appl.
Environ. Microbiol. (2000) 66: 80-6.
Julienne MC, Alonso MJ, GÓMez Amoza JL and
Benoit JP. Preparation of poly(D,L-Lactide/Glycolide)
nanoparticles of controlled particle size distribution:
Application of experimental designs. Drug Dev. Ind.
Pharm. (1992) 18: 1063-77.
Ibrahim H, Bindschaedler C, Doelker E, Buri P and
Gurny R. Aqueous nanodispersions prepared by a
salting-out process. Int. J. Pharm. (1992) 87: 239-46.
Leorux JC, Allemann E, Doelker E and Gurny R.
New approach for the preparation of nanoparticles by
an emulsification-diffusion method. Eur. J. Pharm.
Biopharm. (1995) 41: 14-8.
Elsayed A, Al-Remawi M, Qinna N, Farouk A, Al-
Sou’od K and Badwan A. Chitosan–sodium lauryl
sulfate nanoparticles as a carrier system for the in-vivo
delivery of oral insulin. AAPS PharmSciTech. (2011)
12: 958-64.
Rojanarata T, Petchsangsai M, Opanasopit P,
Ngawhirunpat T, Ruktanonchai U, Sajomsang W
and Tantayanon S. Methylated N-(4-N ,N -dimet
hyl aminob en zyl) chitosan for novel effective gene
carriers. Eur. J. Pharm. Biopharm. (2008) 70: 207-14.
Yoo HS, Lee JE, Chung H, Kwon IC and Jeong SY. Self-
assembled nanoparticles containing hydrophobically
modified glycol chitosan for gene delivery. J. Control.
Release (2005) 103: 235-43.
Sandri G, Rossi S, Bonferoni MC, Ferrari F, Zambito
Y, Di Colo G and Caramella C. Buccal penetration
enhancement properties of N-trimethyl chitosan:
Influence of quaternization degree on absorption of a
high molecular weight molecule. Int. J. Pharm. (2005)
297: 146-55.
Sandri G, Bonferoni MC, Rossi S, Ferrari F, Gibin S,
Zambito Y, Di Colo G and Caramella C. Nanoparticles
based on N-trimethylchitosan: Evaluation of
absorption properties using in-vitro (Caco-2 cells) and
ex-vivo (excised rat jejunum) models. Eur. J. Pharm.
Biopharm. (2007) 65: 68-77.
Helgason T, Awad TS, Kristbergsson K, McClements
DJ and Weiss J. Effect of surfactant surface coverage
on formation of solid lipid nanoparticles (SLN). J.
Colloid Interface Sci. (2009) 334: 75-81.
Mohanraj VJ and Chen Y. Nanoparticles – A Review.
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
New chitosan derivative for insulin oral delivery459
Trop. J. Pharm. Res. (2006) 5: 561-73.
Wada R, Hyon SH and Ikada Y. Lactic acid oligomer
microspheres containing hydrophilic drugs. J. Pharm.
Sci. (1990) 79: 919-24.
Fresta M, Puglisi G, Giammona G, Cavallaro G,
Micali N and Furneri PM. Pefloxacine mesilate-
and ofloxacin-loaded polyethylcyanoacrylate
nanoparticles: Characterization of the colloidal drug
carrier formulation. J. Pharm. Sci. (1995) 84: 895-902.
Uchida T, Yagi A, Oda Y, Nakada Y and Goto S.
Instability of bovine insulin in poly(lactide-co-
glycolide) (PLGA) microspheres. Chem. Pharm. Bull.
(1996) 44: 235-6.
Werle M, Takeuchi H and Bernkop-Schnurch A.
Modified chitosans for oral drug delivery. J. Pharm.
Sci. (2009) 98: 1643-56.
Di Colo G, Zambito Y and Zaino C. Polymeric
enhancers of mucosal epithelia permeability: Synthesis,
transepithelial penetration-enhancing properties,
mechanism of action, safety issues. J. Pharm. Sci .
(2008) 97: 1652-80.
Reis CP, Veiga FJ, Ribeiro AJ, Neufeld RJ and Damge
C. Nanoparticulate biopolymers deliver insulin orally
eliciting pharmacological response. J. Pharm. Sci .
(2008) 97: 5290-305.
(33)
(34)
(35)
(36)
(37)
(38)
Sadeghi AM, Dorkoosh FA, Avadi MR, Saadat P,
Rafiee-Tehrani M and Junginger HE. Preparation,
characterization and antibacterial activities of chitosan,
N-trimethyl chitosan (TMC) and N-diethylmethyl
chitosan (DEMC) nanoparticles loaded with insulin
using both the ionotropic gelation and polyelectrolyte
complexation methods. Int. J. Pharm. (2008) 355: 299-
306.
Mahobia S, Bajpai J and Bajpai AK. An in-vitro
investigation of swelling controlled delivery of insulin
from egg albumin nanocarrier. Iran. J. Pharm. Res .
(2016) 15: 695-711.
Mahjub R, Heidari Shayesteh T, Radmehr M, Vafei SY,
Amini M, Dinarvand R and Dorkoosh FA. Preparation
and optimization of N-trimethyl-O-carboxymethyl
chitosan nanoparticles for delivery of low-molecular-
weight heparin. Pharm. Dev. Technol. (2016) 21: 14-
25.
Mahjub R, Radmehr M, Dorkoosh FA, Ostad SN and
Rafiee-Tehrani M. Lyophilized insulin nanoparticles
prepared from quaternized N-aryl derivatives of
chitosan as a new strategy for oral delivery of insulin:
in-vitro, ex-vivo and in-vivo characterizations. Drug
Dev. Ind. Pharm. (2014) 40: 1645-59
)